Using 3D Echocardiography to Improve Device Closure for Atrial Septal Defect
Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
This study tests if using 3D heart imaging can help doctors choose the right size device to close holes in the heart for people with atrial septal defects.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT02097758 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of three-dimensional transesophageal echocardiography in determining the optimal device size for closing atrial septal defects (ASD). The investigators aim to predict the correct device size and validate a previously developed formula before performing the device closure procedure. By utilizing advanced imaging techniques, the study seeks to enhance the accuracy of ASD closures and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are suitable for atrial septal defect closure.
Not a fit: Patients with multiple atrial septal defects or other heart diseases requiring open heart surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and safer device closures for patients with atrial septal defects.
How similar studies have performed: Previous studies have shown promise in using advanced echocardiographic techniques for similar procedures, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 year-old * Susceptible indication for atrial septal defect closure * Potential candidate for device closure Exclusion Criteria: * Poor candidate for device closure: multiple ASDs, ect * Other heart disease requiring open heart surgery
Where this trial is running
Seoul
- Asan Medical Center — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Jong-Min Song, MD PhD — Asan Medical Center
- Study coordinator: Jong-Min Song, MD,PhD
- Email: jmsong@amc.seoul.kr
- Phone: +82-2-3010-3168
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.